Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroQuinolones: from antibiotics to autoinducers.Coagulase negative staphylococcal infections.Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis)In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy.Penetration of ciprofloxacin into heart valves, myocardium, mediastinal fat, and sternal bone marrow in humans.In vitro activities of five new quinolones against 88 genital and neonatal Haemophilus isolates.Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.Ciprofloxacin activity in cyst fluid from polycystic kidneys.Hepatobiliary kinetics and excretion of ciprofloxacin.Comparative in vitro activities of teicoplanin, vancomycin, oxacillin, and other antimicrobial agents against bacteremic isolates of gram-positive cocciEfficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections.Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.In vitro evaluation of tigemonam, a novel oral monobactam.Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.Open, prospective study of the clinical efficacy of ciprofloxacin.Comparative study of cefoperazone and spectinomycin for treatment of uncomplicated gonorrhea in men.Ciprofloxacin penetration into extravascular spaces in a rabbit model.In vitro activity of ciprofloxacin combined with azlocillin.Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.Comparative trial of single-dose ciprofloxacin and ampicillin plus probenecid for treatment of gonococcal urethritis in men.Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.Temperature-dependent in vitro antimicrobial activity of four 4-quinolones and oxytetracycline against bacteria pathogenic to fishIn vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem?Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disksA review of the antimicrobial activity of the fluoroquinolones.Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Norfloxacin: clinical pharmacology and clinical use.Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.Current problems of chemotherapy of infections with coagulase-negative staphylococci.Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production.In vitro evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.Factors influencing the in vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620.Evaluation of the in vitro bactericidal action of ciprofloxacin on cells of Escherichia coli in the logarithmic and stationary phases of growth.
P2860
Q24670241-C7E713B1-A901-4450-8944-1FECF141116DQ34133116-B9104346-C9DA-4374-9B41-A3D96A878FC9Q34485243-94148FEF-FBCE-4078-9EBD-825925630F29Q35124207-4C8C46D3-C072-4F15-A2D2-6192C02E67A6Q35243584-0A725BE4-9552-4C57-ADDE-E50704533A9EQ35250004-A8A9EFF8-3DD2-4795-9F6C-D3E264BDE941Q35290133-0B03A064-213D-4792-8177-13E7B395444DQ35299812-337E3540-00E5-478E-8972-34F2E610053EQ35303163-B2B542A6-A3FA-4259-9E00-D9658AED3D1AQ35308712-D8763B22-4A04-49D8-8086-14D9550E9164Q35312303-E1E0A231-D491-4404-91FB-88162AB9B32CQ35361659-335F4834-78CE-4EF8-9C0F-FC6A274C340FQ35536165-61D7C6D2-FC99-4B98-A35A-CA786D0C2E2EQ35536186-B53E83BE-7382-49DA-863E-3AF52F3FB766Q35536519-DE968EDF-152E-4BA4-B243-8CB76E0D84D9Q35538661-7C09BA8F-3C1F-4E88-9831-5AEF113DF021Q35549430-6D09EDBE-5C64-42CC-9314-303F7EB328BAQ35570539-5AAB7951-2C10-4F77-B65E-2C8A04A0D949Q35571702-25DA8768-1F90-4F20-8FBC-44701188B699Q35575504-0A7C8895-E411-4B87-A810-B20FF64F7BCDQ35641275-7F9DF24A-A91A-4896-89F6-D7C9AFEFFA05Q35648175-680233DB-C723-438E-8803-BF7E90A65966Q35650708-9C212A87-DB76-40B1-BD7D-4BF711246C76Q35651395-42063D9E-209A-4153-94D2-BD8B16F6A867Q35653930-C12CDAD0-B667-41EA-8988-6701256C4225Q35894252-33595CF1-1EAC-4F9F-BEE4-3D1EA8013FC8Q36456932-B7338E9D-F81C-483E-8B43-F64B0E1695F1Q37180294-F17A2412-5B15-46AA-9D52-646A1CEB57B0Q37190660-AE91D74B-141C-474D-8548-DD08984487FAQ37281766-F87D206E-8AD5-4CD3-A567-E15536AFD1C4Q37834318-EA302B7B-E53B-4779-9524-B5098E88264CQ38520641-5AAD53FD-BFC6-4143-8C70-932C6493B595Q39214819-6AD5FA30-948D-4440-B6E3-DBF36CC5A5B0Q39681144-9CC34689-72D4-426E-91F6-2CD9C724979FQ39730719-DEB1B835-C72E-4F39-9002-AFAD360B59DDQ39741092-418C6F3D-A88F-4586-AF82-56EF815FD51CQ39814933-3992A32A-1722-4DB2-B5F5-FEFE0655FA41Q39834358-CAC0145C-B0A3-4567-8EB5-F914BADD6E3FQ39834684-914CFA51-171F-4A1C-80BC-7E8AFA8098D9Q39850437-7C47DBE9-AFF0-475A-BD1C-7CEB81B5EE78
P2860
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@ast
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@en
type
label
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@ast
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@en
prefLabel
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@ast
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@en
P2093
P2860
P356
P1476
Antibacterial activities of ci ...... cinoxacin, and nalidixic acid
@en
P2093
P2860
P304
P356
10.1128/AAC.25.5.633
P407
P577
1984-05-01T00:00:00Z